Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study. (3rd June 2017)

• Record Type: Journal Article
• Authors: Qin, Yong; Petaccia de Macedo, Mariana; Reuben, Alexandre; Forget, Marie-Andrée; Haymaker, Cara; Bernatchez, Chantale; Spencer, Christine N.; Gopalakrishnan, Vancheswaran; Reddy, Sujan; Cooper, Zachary A.; Fulbright, Orenthial J.; Ramachandran, Renjith; Wahl, Arely; Flores, Esteban; Thorsen, Shawne T.; Tavera, Rene J.; Conrad, Claudius; Williams, Michelle D.; Tetzlaff, Michael T.; Wang, Wei-Lien; Gombos, Dan S.; Esmaeli, Bita; Amaria, Rodabe N.; Hwu, Patrick; Wargo, Jennifer A.; Lazar, Alexander J.; Patel, Sapna P.
• Is Part Of: Oncoimmunology. Volume 6:Number 6(2017)
• Publication Date: 2017-06-03
• Subjects: Cutaneous melanoma -- immune profile -- tumor infiltrating lymphocytes -- uveal melanoma; Tumors -- Immunological aspects -- Periodicals; Neoplasms -- therapy -- Periodicals; Immunotherapy -- Periodicals; 616.994
• DOI: 10.1080/2162402X.2017.1321187
• Languages: English
• ISSNs: 2162-402X

Abstract

ABSTRACT: The low response rates to immunotherapy in uveal melanoma (UM) sharply contrast with reputable response rates in cutaneous melanoma (CM) patients. To characterize the mechanisms responsible for resistance to immunotherapy in UM, we performed immune profiling in tumors from 10 metastatic UM patients and 10 metastatic CM patients by immunohistochemistry (IHC). Although there is no difference in infiltrating CD8 + T cells between UM and CM, a significant decrease in programmed death-1 (PD-1)-positive lymphocytes was observed and lower levels of programmed death ligand-1 (PD-L1) in UM metastases compared with CM metastases. Tumors from metastatic UM patients showed a lower success rate of tumor-infiltrating lymphocyte (TIL) growth compared with metastatic CM (45% vs. 64% success), with a significantly lower quantity of UM TIL expanded overall. These studies suggest that UM and CM are immunologically distinct, and provide potential explanation for the impaired success of immunotherapy in UM.